Portage Biotech Statistics
Total Valuation
Portage Biotech has a market cap or net worth of $9.12 million. The enterprise value is $7.38 million.
Important Dates
The next estimated earnings date is Tuesday, August 26, 2025, before market open.
| Earnings Date | Aug 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Portage Biotech has 1.65 million shares outstanding. The number of shares has increased by 20.73% in one year.
| Current Share Class | 1.65M |
| Shares Outstanding | 1.65M |
| Shares Change (YoY) | +20.73% |
| Shares Change (QoQ) | +2.57% |
| Owned by Insiders (%) | 48.62% |
| Owned by Institutions (%) | 6.83% |
| Float | 809,815 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.42 |
| P/TBV Ratio | 6.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.08, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.08 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -367.44 |
Financial Efficiency
Return on equity (ROE) is -198.89% and return on invested capital (ROIC) is -21.61%.
| Return on Equity (ROE) | -198.89% |
| Return on Assets (ROA) | -15.45% |
| Return on Invested Capital (ROIC) | -21.61% |
| Return on Capital Employed (ROCE) | -641.46% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$9.61M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -9.49M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.34% in the last 52 weeks. The beta is 0.67, so Portage Biotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +25.34% |
| 50-Day Moving Average | 7.95 |
| 200-Day Moving Average | 5.88 |
| Relative Strength Index (RSI) | 36.54 |
| Average Volume (20 Days) | 236,112 |
Short Selling Information
The latest short interest is 8,761, so 0.53% of the outstanding shares have been sold short.
| Short Interest | 8,761 |
| Short Previous Month | 16,234 |
| Short % of Shares Out | 0.53% |
| Short % of Float | 1.08% |
| Short Ratio (days to cover) | 0.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.76M |
| Pretax Income | -170.41M |
| Net Income | -67.28M |
| EBITDA | -11.72M |
| EBIT | -11.76M |
| Earnings Per Share (EPS) | -$63.79 |
Full Income StatementBalance Sheet
The company has $1.76 million in cash and $28,000 in debt, giving a net cash position of $1.74 million or $1.06 per share.
| Cash & Cash Equivalents | 1.76M |
| Total Debt | 28,000 |
| Net Cash | 1.74M |
| Net Cash Per Share | $1.06 |
| Equity (Book Value) | 695,000 |
| Book Value Per Share | 1.25 |
| Working Capital | 1.81M |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.80M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.80M |
| FCF Per Share | -$5.95 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |